The chances of the Health Department offering GLP-1 drugs to public sector patients for obesity any time soon are remote, reports Business Day. While the WHO backed the treatments for long-term obesity almost a year ago, the department has yet to begin assessing whether to make them available, a senior official has confirmed. The national […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.